BRAIN AG announces strategic collaboration with BluCon Biotech GmbH
Joint R&D work aims at microbial strain development for the production of high-value chemicals including bioplastics
BluCon Biotech GmbH develops a consolidated bioprocess for the production of lactic acid from industrial or agricultural cellulosic waste based on the company’s proprietary bacteria. BluCon’s objective is to achieve very low production costs in order to allow the production of PLA-based bioplastic (poly lactic acid) at costs competitive to fossil fuel-based plastics.
The aim of the R&D collaboration is the further improvement of BluCon’s microorganisms with classical biotechnologies enabling them to produce within their metabolisms the required product in a highly efficient manner.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.